| Year |
Citation |
Score |
| 2024 |
Li M, Smith BJ, Lee J, Petr J, Anders NM, Wiseman R, Rudek MA, Ambinder RF, Desai PJ. Nelfinavir inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly. Infectious Agents and Cancer. 19: 7. PMID 38439055 DOI: 10.1186/s13027-024-00566-7 |
0.309 |
|
| 2023 |
Li M, Smith B, Lee J, Petr J, Wiseman R, Anders N, Rudek M, Ambinder R, Desai P. Nelfinavir Inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly. Research Square. PMID 37986957 DOI: 10.21203/rs.3.rs-3552962/v1 |
0.334 |
|
| 2021 |
Lee J, Stone J, Desai P, Kosowicz JG, Liu JO, Ambinder RF. Arsenicals, the Integrated Stress Response, and Epstein-Barr Virus Lytic Gene Expression. Viruses. 13. PMID 33946406 DOI: 10.3390/v13050812 |
0.383 |
|
| 2021 |
Ambinder RF. Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 217: 197-207. PMID 33200367 DOI: 10.1007/978-3-030-57362-1_9 |
0.328 |
|
| 2019 |
Lee J, Kosowicz JG, Hayward SD, Desai P, Stone J, Lee JM, Liu JO, Ambinder RF. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression Without Virion Production. Journal of Virology. PMID 31341058 DOI: 10.1128/Jvi.00998-19 |
0.41 |
|
| 2019 |
Keller MD, Darko S, Lang H, Ransier A, Lazarski CA, Wang Y, Hanley PJ, Davila BJ, Heimall JR, Ambinder RF, Barrett AJ, Rooney CM, Heslop HE, Douek DC, Bollard CM. T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy. British Journal of Haematology. PMID 31219185 DOI: 10.1111/bjh.16053 |
0.303 |
|
| 2018 |
Ambinder RF. A viral protein kinase drug target for tumors? The Journal of Clinical Investigation. PMID 29733293 DOI: 10.1172/JCI121080 |
0.343 |
|
| 2018 |
Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, Henry D, Ratner L, Aboulafia D, Lee JY, Ambinder RF, Mitsuyasu R, Noy A. Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical Lymphoma, Myeloma & Leukemia. PMID 29426719 DOI: 10.1016/J.Clml.2018.01.004 |
0.323 |
|
| 2018 |
Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin J, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok-Williams M, Samaneka W, ... ... Ambinder R, et al. As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29365083 DOI: 10.1093/Cid/Ciy044 |
0.304 |
|
| 2017 |
Kosowicz JG, Lee J, Peiffer B, Guo Z, Chen J, Liao G, Hayward SD, Liu JO, Ambinder RF. Drug modulators of B cell signaling pathways and Epstein-Barr virus lytic activation. Journal of Virology. PMID 28566383 DOI: 10.1128/Jvi.00747-17 |
0.532 |
|
| 2017 |
Patel S, Lam S, Sung J, Cruz R, Goonetilleke N, Xu Y, Kuruc J, Gay C, Jones B, Shpall E, Margolis D, Ambinder R, Bollard C. HIV specific T cells generated from HIV naive adult and cord blood donors target a range of novel viral epitopes—implications for a cure strategy after allogeneic HSCT and CBT Cytotherapy. 19: S41-S42. DOI: 10.1016/J.Jcyt.2017.02.097 |
0.302 |
|
| 2016 |
Ratner L, Rauch D, Abel H, Caruso B, Noy A, Barta SK, Parekh S, Ramos JC, Ambinder R, Phillips A, Harding J, Baydoun HH, Cheng X, Jacobson S. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood Cancer Journal. 6: e408. PMID 27015285 DOI: 10.1038/Bcj.2016.21 |
0.396 |
|
| 2016 |
Patel S, Lam S, Cruz CR, Wright K, Cochran C, Ambinder R, Shpall E, Bollard C. 763. HIV-Specific T Cells Can Be Expanded from Virus-Naive Donors to Target a Range of Viral Epitopes: Implications for a Cure Strategy After Allogeneic HSCT Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)33571-7 |
0.356 |
|
| 2015 |
Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, et al. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leukemia & Lymphoma. 1-4. PMID 26674561 DOI: 10.3109/10428194.2015.1113281 |
0.372 |
|
| 2015 |
Kanakry J, Ambinder R. The Biology and Clinical Utility of EBV Monitoring in Blood. Current Topics in Microbiology and Immunology. 391: 475-99. PMID 26428386 DOI: 10.1007/978-3-319-22834-1_17 |
0.414 |
|
| 2015 |
Lee HG, Kim H, Kim EJ, Park PG, Dong SM, Choi TH, Kim H, Chong CR, Liu JO, Chen J, Ambinder RF, Hayward SD, Park JH, Lee JM. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation. Oncotarget. PMID 26427042 DOI: 10.18632/Oncotarget.5041 |
0.54 |
|
| 2015 |
Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 126: 160-6. PMID 25957391 DOI: 10.1182/Blood-2015-01-623900 |
0.331 |
|
| 2015 |
Magid Diefenbach CS, Li H, Kahl BS, Robertson MJ, Cohen J, Advani RH, Ambinder R, Fenske TS, Ansell SM. A phase I study with an expansion cohort of the combination of ipilimumab and brentuximab vedotin in patients with relapsed/refractory Hodgkin lymphoma: A trial of the ECOG-ACRIN Cancer Research Group (E4412). Journal of Clinical Oncology. 33: TPS8602-TPS8602. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps8602 |
0.388 |
|
| 2015 |
Ratner L, Ramos J, Noy A, Barta S, Parikh S, Phillips A, Ambinder R, Rauch D, Harding J, Baydoun H, Cheng X, Caruso B, Jacobson S. Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma Retrovirology. 12. DOI: 10.1186/1742-4690-12-S1-P21 |
0.373 |
|
| 2014 |
Kalu NN, Desai PJ, Shirley CM, Gibson W, Dennis PA, Ambinder RF. Nelfinavir inhibits maturation and export of herpes simplex virus 1. Journal of Virology. 88: 5455-61. PMID 24574416 DOI: 10.1128/Jvi.03790-13 |
0.756 |
|
| 2014 |
Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. The American Journal of Surgical Pathology. 38: 426-32. PMID 24525514 DOI: 10.1097/Pas.0000000000000128 |
0.766 |
|
| 2014 |
Haverkos BM, Hemminger J, Geyer SM, Bingman A, Deusen KV, Lustberg M, Wong H, Gru A, Ambinder R, Baiocchi RA, Porcu P. Prognostic implications, predictive value, and latency analysis of Epstein-Barr virus (EBV) DNA in advanced stage cutaneous T-cell lymphoma (AS-CTCL). Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E19518 |
0.418 |
|
| 2014 |
Alvarnas J, Rademacher JL, Wang Y, Little RF, Akpek G, Ayala E, Devine S, Kaplan L, Noy A, Popat U, Thompson J, Horowitz MH, Mendizabal A, Navarro WH, Ambinder R. Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) Trial Blood. 124: 674-674. DOI: 10.1182/Blood.V124.21.674.674 |
0.348 |
|
| 2014 |
Kanakry JA, Ambinder RF. Human herpesviruses: Malignant lymphoma Viral Infections of Humans: Epidemiology and Control. 933-951. DOI: 10.1007/978-1-4899-7448-8_40 |
0.387 |
|
| 2013 |
Kanakry JA, Ambinder RF. EBV-related lymphomas: new approaches to treatment. Current Treatment Options in Oncology. 14: 224-36. PMID 23549980 DOI: 10.1007/s11864-013-0231-y |
0.384 |
|
| 2013 |
Vose JM, Carter S, Burns LJ, Ayala E, Press OW, Moskowitz CH, Stadtmauer EA, Mineshi S, Ambinder R, Fenske T, Horowitz M, Fisher R, Tomblyn M. Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1662-8. PMID 23478060 DOI: 10.1200/Jco.2012.45.9453 |
0.339 |
|
| 2013 |
Zeidan A, Bolaños-Meade J, Kasamon Y, Aoki J, Borowitz M, Swinnen L, Symons H, Luznik L, Fuchs E, Jones R, Ambinder R. Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma. Leukemia & Lymphoma. 54: 655-7. PMID 22845310 DOI: 10.3109/10428194.2012.717082 |
0.358 |
|
| 2012 |
Gellert LL, Kasamon YL, Lemas MV, Toure MV, Ambinder RF. Cell-free EBV DNA in Hodgkin lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 7. PMID 28142412 DOI: 10.1200/jco.2012.30.30_suppl.7 |
0.302 |
|
| 2012 |
Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins. Bmc Cancer. 12: 125. PMID 22458933 DOI: 10.1186/1471-2407-12-125 |
0.321 |
|
| 2012 |
Durand C, Ambinder R, Blankson J, Forman S. HIV-1 and hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: S172-6. PMID 22226103 DOI: 10.1016/J.Bbmt.2011.10.027 |
0.364 |
|
| 2012 |
Kalu N, Shirley C, Ambinder R. ER stress activates lytic gene expression in KSHV-associated tumor cell lines Infectious Agents and Cancer. 7. DOI: 10.1186/1750-9378-7-S1-P33 |
0.756 |
|
| 2012 |
Shirley CM, Kalu N, Shamay M, Ambinder RF. Epstein-Barr virus lytic gene expression is tightly linked to ER stress but not cytotoxicity with bortezomib or nelfinavir Infectious Agents and Cancer. 7. DOI: 10.1186/1750-9378-7-S1-P32 |
0.778 |
|
| 2011 |
Li R, Zhu J, Xie Z, Liao G, Liu J, Chen MR, Hu S, Woodard C, Lin J, Taverna SD, Desai P, Ambinder RF, Hayward GS, Qian J, Zhu H, et al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host & Microbe. 10: 390-400. PMID 22018239 DOI: 10.1016/J.Chom.2011.08.013 |
0.32 |
|
| 2011 |
Zheng D, Wan J, Cho YG, Wang L, Chiou CJ, Pai S, Woodard C, Zhu J, Liao G, Martinez-Maza O, Qian J, Zhu H, Hayward GS, Ambinder RF, Hayward SD. Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray. The Journal of Infectious Diseases. 204: 1683-91. PMID 21990424 DOI: 10.1093/Infdis/Jir645 |
0.307 |
|
| 2011 |
Gladstone DE, Bolaños-Meade J, Huff CA, Zahurak M, Flinn I, Borrello I, Luznik L, Fuchs E, Kasamon Y, Matsui W, Powell J, Levitsky H, Brodsky RA, Ambinder R, Jones RJ, et al. High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas. Leukemia & Lymphoma. 52: 2076-81. PMID 21756035 DOI: 10.3109/10428194.2011.594191 |
0.393 |
|
| 2011 |
Shirley CM, Ambinder RF. When differentiation goes viral. Blood. 117: 5790-1. PMID 21636716 DOI: 10.1182/Blood-2011-04-344135 |
0.766 |
|
| 2011 |
Shirley CM, Chen J, Shamay M, Li H, Zahnow CA, Hayward SD, Ambinder RF. Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. Blood. 117: 6297-303. PMID 21447826 DOI: 10.1182/Blood-2011-01-332379 |
0.773 |
|
| 2010 |
Murray PG, Fan Y, Davies G, Ying J, Geng H, Ng KM, Li H, Gao Z, Wei W, Bose S, Anderton J, Kapatai G, Reynolds G, Ito A, Marafioti T, ... ... Ambinder R, et al. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. The American Journal of Pathology. 177: 1480-90. PMID 20709797 DOI: 10.2353/Ajpath.2010.100052 |
0.41 |
|
| 2010 |
Wang L, Zheng D, Zhu J, Liao G, Woodard C, Chiou C, Hayward G, Desai P, Ambinder R, Zhu H, Hayward SD. Development of a proteomic platform for EBV and KSHV serological screening Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A18 |
0.385 |
|
| 2009 |
Ratner L, Harrington W, Feng X, Grant C, Jacobson S, Noy A, Sparano J, Lee J, Ambinder R, Campbell N, Lairmore M. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. Plos One. 4: e4420. PMID 19204798 DOI: 10.1371/Journal.Pone.0004420 |
0.454 |
|
| 2009 |
Hobbs R, Fu D, Pomper M, Ambinder R, Sgouros G. Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling Infectious Agents and Cancer. 4. DOI: 10.1186/1750-9378-4-S2-P23 |
0.347 |
|
| 2008 |
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nature Medicine. 14: 1118-22. PMID 18776891 DOI: 10.1038/Nm.1864 |
0.711 |
|
| 2008 |
Perkins EM, Anacker D, Davis A, Sankar V, Ambinder RF, Desai P. Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids. Journal of Virology. 82: 7201-11. PMID 18463150 DOI: 10.1128/JVI.00423-08 |
0.301 |
|
| 2007 |
Ambinder RF. Epstein-barr virus and hodgkin lymphoma. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 204-9. PMID 18024631 DOI: 10.1182/asheducation-2007.1.204 |
0.305 |
|
| 2007 |
Fu DX, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, Chong JM, Ambinder RF, Pomper MG. Virus-associated tumor imaging by induction of viral gene expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1453-8. PMID 17332288 DOI: 10.1158/1078-0432.Ccr-06-2295 |
0.736 |
|
| 2007 |
Epeldegui M, Hung YP, McQuay A, Ambinder RF, MartÃnez-Maza O. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Molecular Immunology. 44: 934-42. PMID 16730063 DOI: 10.1016/J.Molimm.2006.03.018 |
0.339 |
|
| 2007 |
Fu D, Chong J, Foss C, Fox J, Wang S, Green G, Chen J, Lemas MV, Pomper M, Ambinder R. Imaging and therapy for Epstein-Barr virus-associated gastric cancer Journal of Clinical Oncology. 25: 4644-4644. DOI: 10.1200/Jco.2007.25.18_Suppl.4644 |
0.385 |
|
| 2007 |
Wang Q, Peacock C, Hensley K, Brennan S, Merchant A, Jones E, Freed I, Ambinder R, McGovern K, Tremblay M, Watkins DN, Matsui W. Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas. Blood. 110: 3582-3582. DOI: 10.1182/Blood.V110.11.3582.3582 |
0.392 |
|
| 2007 |
Lechowicz MJ, Lee J, Dittmer D, Krown S, Said J, Ambinder RF. A Pilot Trial of Valproic Acid in Patients with Kaposi’s Sarcoma: A Multi-Center Trial of the AIDS Malignancy Consortium. Blood. 110: 2279-2279. DOI: 10.1182/Blood.V110.11.2279.2279 |
0.352 |
|
| 2007 |
Ambinder RF, Cesarman E. Clinical and pathological aspects of EBV and KSHV infection Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 885-903. DOI: 10.1017/CBO9780511545313.051 |
0.314 |
|
| 2006 |
Krown SE, Lee JY, Lin L, Fischl MA, Ambinder R, Von Roenn JH. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 149-53. PMID 16394845 DOI: 10.1097/01.Qai.0000194237.15831.23 |
0.354 |
|
| 2006 |
Chen J, Chong C, Hsieh W, Fu D, Lemas V, Liu JO, Ambinder RF. Screening a library of FDA-approved drugs identifies agents that induce lytic viral infection in EBV-associated tumors Journal of Clinical Oncology. 24: 2002-2002. DOI: 10.1200/jco.2006.24.18_suppl.2002 |
0.403 |
|
| 2006 |
Epeldegui M, Ping Hung Y, McQuay A, Ambinder R, Martinez-Maza O. F.130. Epstein-Barr Virus Infection Induces the Expression of Key Genes Involved in Somatic Hypermutation and Oncogene Mutation Clinical Immunology. 119: S96-S97. DOI: 10.1016/J.Clim.2006.04.170 |
0.379 |
|
| 2005 |
Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors Clinical Cancer Research. 11: 6442-6449. PMID 16166418 DOI: 10.1158/1078-0432.Ccr-05-0267 |
0.434 |
|
| 2005 |
Fu D, Pomper M, Foss C, Ambinder R. Retrovirology. 2: S22. DOI: 10.1186/1742-4690-2-S1-S22 |
0.475 |
|
| 2004 |
Glaser SL, Gulley ML, Borowitz MJ, Craig FE, Mann RB, Stewart SL, Shema SJ, Ambinder RF. Inter- and intra-observer reliability of Epstein-Barr virus detection in Hodgkin lymphoma using histochemical procedures. Leukemia & Lymphoma. 45: 489-97. PMID 15160910 DOI: 10.1080/1042819032000141310 |
0.313 |
|
| 2004 |
Murray PG, Qiu GH, Fu L, Waites ER, Srivastava G, Heys D, Agathanggelou A, Latif F, Grundy RG, Mann JR, Starczynski J, Crocker J, Parkes SE, Ambinder RF, Young LS, et al. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma. Oncogene. 23: 1326-31. PMID 14961078 DOI: 10.1038/Sj.Onc.1207313 |
0.356 |
|
| 2003 |
Ambinder RF. Epstein-Barr Virus-Associated Lymphoproliferative Disorders Reviews in Clinical and Experimental Hematology. 7: 362-374. PMID 15129648 |
0.416 |
|
| 2003 |
Huang J, Chen H, Hutt-Fletcher L, Ambinder RF, Hayward SD. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. Journal of Virology. 77: 13267-74. PMID 14645583 DOI: 10.1128/Jvi.77.24.13267-13274.2003 |
0.321 |
|
| 2003 |
Ambinder RF. Viruses as potential targets for therapy in HIV-associated malignancies Hematology/Oncology Clinics of North America. 17: 697-702. PMID 12852651 |
0.327 |
|
| 2002 |
Lechowicz MJ, Lin L, Ambinder RF. Epstein-Barr virus DNA in body fluids. Current Opinion in Oncology. 14: 533-7. PMID 12192273 DOI: 10.1097/00001622-200209000-00010 |
0.306 |
|
| 2002 |
Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM, Alcendor DJ, Zong JC, Ambinder RF, Hayward GS. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. Journal of Virology. 76: 3421-39. PMID 11884567 DOI: 10.1128/Jvi.76.7.3421-3439.2002 |
0.722 |
|
| 2002 |
Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ, Ambinder RF. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma American Journal of Clinical Pathology. 117: 259-267. PMID 11863222 DOI: 10.1309/MMAU-0QYH-7BHA-W8C2 |
0.335 |
|
| 2001 |
Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas. Human Pathology. 32: 963-9. PMID 11567226 DOI: 10.1053/hupa.2001.27114 |
0.323 |
|
| 2001 |
Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting European Journal of Cancer. 37: 1209-1216. PMID 11423253 DOI: 10.1016/S0959-8049(01)00123-X |
0.416 |
|
| 2001 |
Moore SM, Cannon JS, Tanhehco YC, Hamzeh FM, Ambinder RF. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrobial Agents and Chemotherapy. 45: 2082-91. PMID 11408227 DOI: 10.1128/Aac.45.7.2082-2091.2001 |
0.795 |
|
| 2001 |
Ciufo DM, Cannon JS, Poole LJ, Wu FY, Murray P, Ambinder RF, Hayward GS. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. Journal of Virology. 75: 5614-26. PMID 11356969 DOI: 10.1128/Jvi.75.12.5614-5626.2001 |
0.706 |
|
| 2001 |
Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, Scadden D, Kaplan L, Ambinder R, Levine A, Harrington W, Grochow L, Flexner C, Tan B, Straus D. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy Journal of Clinical Oncology. 19: 2171-2178. PMID 11304769 DOI: 10.1200/Jco.2001.19.8.2171 |
0.361 |
|
| 2001 |
Chen H, Lee JM, Zong Y, Borowitz M, Ng MH, Ambinder RF, Hayward SD. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. Journal of Virology. 75: 2929-37. PMID 11222718 DOI: 10.1128/JVI.75.6.2929-2937.2001 |
0.328 |
|
| 2000 |
Yang J, Tao Q, Flinn IW, Murray PG, Post LE, Ma H, Piantadosi S, Caligiuri MA, Ambinder RF. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response Blood. 96: 4055-4063. PMID 11110673 DOI: 10.1182/Blood.V96.13.4055.H8004055_4055_4063 |
0.345 |
|
| 2000 |
Cannon JS, Ciufo D, Hawkins AL, Griffin CA, Borowitz MJ, Hayward GS, Ambinder RF. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. Journal of Virology. 74: 10187-93. PMID 11024147 DOI: 10.1128/Jvi.74.21.10187-10193.2000 |
0.742 |
|
| 1999 |
Schroeder JR, Saah AJ, Ambinder RF, Martinez-Maza O, Crabb Breen E, Variakojis D, Margolick JB, Jacobson LP, Rowe DT, Hoover DR. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue Clinical Immunology. 93: 239-244. PMID 10600334 DOI: 10.1006/Clim.1999.4793 |
0.315 |
|
| 1999 |
Cannon JS, Nicholas J, Orenstein JM, Mann RB, Murray PG, Browning PJ, DiGiuseppe JA, Cesarman E, Hayward GS, Ambinder RF. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. The Journal of Infectious Diseases. 180: 824-8. PMID 10438372 DOI: 10.1086/314956 |
0.713 |
|
| 1999 |
Qian T, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF. Methylation status of the Epstein-Barr virus major latent promoter C in latrogenic B cell lymphoproliferative disease: Application of PCR-based analysis American Journal of Pathology. 155: 619-625. PMID 10433954 DOI: 10.1016/S0002-9440(10)65157-7 |
0.306 |
|
| 1999 |
Chen H, Lee JM, Wang Y, Huang DP, Ambinder RF, Hayward SD. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Proceedings of the National Academy of Sciences of the United States of America. 96: 9339-44. PMID 10430944 DOI: 10.1073/pnas.96.16.9339 |
0.346 |
|
| 1999 |
Poole LJ, Zong JC, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, Orenstein JM, Reitz MS, Hayward GS. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. Journal of Virology. 73: 6646-60. PMID 10400762 DOI: 10.1128/Jvi.73.8.6646-6660.1999 |
0.644 |
|
| 1999 |
Cannon JS, Hamzeh F, Moore S, Nicholas J, Ambinder RF. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. Journal of Virology. 73: 4786-93. PMID 10233939 DOI: 10.1128/Jvi.73.6.4786-4793.1999 |
0.718 |
|
| 1999 |
Chen H, Smith P, Ambinder RF, Hayward SD. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood. 93: 3026-32. PMID 10216099 |
0.398 |
|
| 1999 |
Echavarria MS, Ray SC, Ambinder R, Dumler JS, Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: Hemorrhagic cystitis as a presenting manifestation of disseminated disease Journal of Clinical Microbiology. 37: 686-689. PMID 9986832 DOI: 10.1128/Jcm.37.3.686-689.1999 |
0.351 |
|
| 1999 |
Ambinder RF, Lemas MV, Moore S, Yang J, Fabian D, Krone C. Epstein-Barr virus and lymphoma Cancer Treatment and Research. 99: 27-45. PMID 9891862 |
0.301 |
|
| 1998 |
Murray PG, Constandinou CM, Crocker J, Young LS, Ambinder RF. Analysis of major histocompatibility complex class I, tap expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease Blood. 92: 2477-2483. PMID 9746788 |
0.358 |
|
| 1998 |
Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive Journal of Virology. 72: 7075-7083. PMID 9696800 DOI: 10.1128/Jvi.72.9.7075-7083.1998 |
0.315 |
|
| 1998 |
Orentas RJ, Lemas MV, Mullin MJ, Colombani PM, Schwarz K, Ambinder R. Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors. Journal of Hematotherapy. 7: 257-61. PMID 9621259 DOI: 10.1089/Scd.1.1998.7.257 |
0.426 |
|
| 1998 |
Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue Blood. 91: 1373-1381. PMID 9454768 DOI: 10.1182/Blood.V91.4.1373 |
0.374 |
|
| 1997 |
Sing AP, Ambinder RF, Hong DJ, Jensen M, Batten W, Petersdorf E, Greenberg PD. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV+ Hodgkin's disease Blood. 89: 1978-1986. PMID 9058719 DOI: 10.1182/Blood.V89.6.1978 |
0.335 |
|
| 1997 |
Moore SM, Ambinder RF. Pharmacologic induction of Epstein-Barr Virus lytic cycle Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A41. DOI: 10.1097/00042560-199704010-00142 |
0.572 |
|
| 1996 |
Flinn IW, Ambinder RF. AIDS primary central nervous system lymphoma Current Opinion in Oncology. 8: 373-376. PMID 9026061 DOI: 10.1097/00001622-199609000-00007 |
0.321 |
|
| 1996 |
Ambinder RF, Robertson KD, Moore SM, Yang J. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma. Seminars in Cancer Biology. 7: 217-26. PMID 8946606 DOI: 10.1006/Scbi.1996.0029 |
0.636 |
|
| 1996 |
Robertson KD, Manns A, Swinnen LJ, Zong JC, Gulley ML, Ambinder RF. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease Blood. 88: 3129-3136. PMID 8874213 DOI: 10.1182/Blood.V88.8.3129.Bloodjournal8883129 |
0.46 |
|
| 1996 |
Murray P, Swinnen L, Constandinou C, Pyle J, Carr T, Hardwick J, Ambinder R. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders [see comments] Blood. 87: 706-711. DOI: 10.1182/Blood.V87.2.706.Bloodjournal872706 |
0.449 |
|
| 1995 |
Caldas C, Ambinder R. Epstein-Barr virus and bone marrow transplantation Current Opinion in Oncology. 7: 102-106. PMID 7756374 DOI: 10.1097/00001622-199503000-00002 |
0.432 |
|
| 1995 |
DiGiuseppe JA, Wu TC, Zehnbauer BA, McDowell PR, Barletta JM, Ambinder RF, Mann RB. Epsiein-Barr virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype Modern Pathology. 8: 553-559. PMID 7675777 |
0.403 |
|
| 1995 |
Siebert JD, Ambinder RF, Napoli VM, Quintanilla-Martinez L, Banks PM, Gulley ML. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus Human Pathology. 26: 1191-1195. PMID 7590691 DOI: 10.1016/0046-8177(95)90192-2 |
0.312 |
|
| 1994 |
Kingma DW, Medeiros LJ, Barletta J, Raffeld M, Mann RB, Ambinder RF, Jaffe ES. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease American Journal of Surgical Pathology. 18: 48-61. PMID 8279628 |
0.338 |
|
| 1994 |
Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens American Journal of Pathology. 145: 239-252. PMID 8053485 |
0.411 |
|
| 1994 |
Robertson KD, Barletta J, Samid D, Ambinder RF. Pharmacologic activation of expression of immunodominant viral antigens: A new strategy for the treatment of Epstein-Barr-virus-associated malignancies Current Topics in Microbiology and Immunology. 194: 145-154. PMID 7534666 DOI: 10.1007/978-3-642-79275-5_18 |
0.353 |
|
| 1993 |
Ryon JJ, Hayward SD, MacMahon EM, Mann RB, Ling Y, Charache P, Phelan JA, Miller G, Ambinder RF. In situ detection of lytic Epstein-Barr virus infection: expression of the NotI early gene and viral interleukin-10 late gene in clinical specimens. The Journal of Infectious Diseases. 168: 345-51. PMID 8393057 DOI: 10.1093/Infdis/168.2.345 |
0.356 |
|
| 1993 |
Barletta JM, Kingma DW, Ling Y, Charache P, Mann RB, Ambinder RF. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection Molecular and Cellular Probes. 7: 105-109. PMID 8391639 DOI: 10.1006/mcpr.1993.1014 |
0.346 |
|
| 1993 |
Ambinder R, Browning P, Lorenzana I, Leventhal B, Cosenza H, Mann R, MacMahon E, Medina R, Cardona V, Grufferman S. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States Blood. 81: 462-467. DOI: 10.1182/Blood.V81.2.462.Bloodjournal812462 |
0.392 |
|
| 1992 |
Mann RB, Wu TC, MacMahon EM, Ling Y, Charache P, Ambinder RF. In situ localization of Epstein-Barr virus in thymic carcinoma Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 5: 363-366. PMID 1323108 |
0.302 |
|
| 1991 |
MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, McArthur JC, Ambinder RF. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 338: 969-73. PMID 1681341 DOI: 10.1016/0140-6736(91)91837-K |
0.367 |
|
| 1990 |
Ambinder RF, Lambe BC, Mann RB, Hayward SD, Zehnbauer BA, Burns WS, Charache P. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Molecular and Cellular Probes. 4: 397-407. PMID 2177846 DOI: 10.1016/0890-8508(90)90030-4 |
0.303 |
|
| 1990 |
Ambinder RF. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1 Hematology/Oncology Clinics of North America. 4: 821-833. PMID 2172203 |
0.407 |
|
| 1990 |
Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. International Journal of Cancer. Journal International Du Cancer. 46: 801-4. PMID 2172169 DOI: 10.1002/ijc.2910460509 |
0.338 |
|
| 1989 |
Staal SP, Ambinder R, Beschorner WE, Hayward GS, Mann R. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease American Journal of Clinical Pathology. 91: 1-5. PMID 2535912 DOI: 10.1093/Ajcp/91.1.1 |
0.398 |
|
| 1984 |
Hayward GS, Ambinder R, Ciufo D, Diane Hayward S, Lafemina RL. Structural Organization of Human Herpesvirus DNA Molecules Journal of Investigative Dermatology. 83: S29-S41. DOI: 10.1038/Jid.1984.17 |
0.334 |
|
| Show low-probability matches. |